Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
multiple-myeloma
multiple myeloma, high risk multiple myeloma, ixazomib, low-dose lenalidomide, maintenance therapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 893463
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.